Hemostatic and fibrinolytic activation is less following cutting balloon angioplasty of the coronary arteries

Japanese Heart Journal

Volumn 45, Issue 3, 2004, Pages 409-417

  Namiki, Atsushi ^a,c   Toma, Hiroko ^a   Nakamura, Masato ^a   Matsuda, Ken Ichi ^a   Hara, Hidehiko ^a   Hara, Hisao ^a   Asahara, Toshiyuki ^a   Soumitsu, Yasunari ^a   Kobayashi, Nobuyuki ^a   Yamaguchi, Tetsu ^a,b  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TORANOMON HOSPITAL   (Japan)

^c TOHO UNIVERSITY   (Japan)

Author keywords

Coronary stenting; Cutting balloon; Fibrinopeptide A; Percutaneous coronary intervention; Plain old balloon angioplasty; Plasminogen activator inhibitor 1; Prothombin fragment 1+2; Thrombin antithrombin III complex

Indexed keywords

ACETYLSALICYLIC ACID; BIOLOGICAL MARKER; CILOSTAZOL; FIBRINOPEPTIDE A; HEPARIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PRAVASTATIN; PROTHROMBIN; THROMBIN ANTITHROMBIN COMPLEX; TICLOPIDINE; WARFARIN; ANTITHROMBIN III; ANTITHROMBIN III PROTEASE COMPLEX; ANTITHROMBIN III-PROTEASE COMPLEX; HEMOSTATIC AGENT; PEPTIDE FRAGMENT; PEPTIDE HYDROLASE; PROTHROMBIN FRAGMENT 1.2; THROMBIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; ELECTIVE SURGERY; FEMALE; FIBRINOLYSIS; HEMOSTASIS; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STABLE ANGINA PECTORIS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; BLOOD; CLINICAL TRIAL; METHODOLOGY; MIDDLE AGED; RADIOGRAPHY; STENT; UNSTABLE ANGINA PECTORIS;

AGED; ANGINA, UNSTABLE; ANGIOPLASTY, BALLOON; ANTITHROMBIN III; CORONARY ANGIOGRAPHY; FEMALE; FIBRINOLYSIS; FIBRINOPEPTIDE A; HEMOSTATICS; HUMANS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PEPTIDE HYDROLASES; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN; STENTS; THROMBIN;

EID: 3442901368     PISSN: 00214868     EISSN: 1348673X     Source Type: Journal    
DOI: 10.1536/jhj.45.409     Document Type: Article

References (13)

1. Barath P, Fishbein MC, Vari S, et al. Cutting balloon: A novel approach to percutaneous angioplasty. Am J Cardiol 1991; 68: 1249-52.
2. Unterberg C, Buchwald AB, Barath P, et al. Cutting balloon coronary angioplasty - Initial clinical experience. Clin Cardiol 1993; 16: 660-4.
3. Schammas NW, Cunningham MJ, Pomerantz RM, et al. Markers of hemostatic activation in affected coronary arteries during angioplasty. Thromb Haemost 1994; 72: 672-5.
4. Oltrona L, Eisenberg PR, Lasala JM, et al. Association of heparin-resistant thrombin activity with acute ischemic complications of coronary interventions. Circulation 1996; 94: 2064-71.
5. Smith AJC, Holt RE, Fitzpatrick K, et al. Transient thrombotic state after abrupt discontinuation of heparin in percutaneous coronary angioplasty. Am Heart J 1996; 131: 434-9.
6. Marmur JD, Merlini PA, Sharma SK, et al. Thrombin generation in human coronary arteries after percutaneous transluminal balloon angioplasty. J Am Coll Cardiol 1994; 24: 1484-91.
7. Haude M, Hafner G, Jablonka A, et al. Guidance of anticoagulation after intracoronary implantation of Palmaz-Schatz stents by monitoring prothrombin and prothrombin fragment 1+2. Am Heart J 1995; 130: 228-38.
8. Ergene O, Seyithanoglu BY, Tastan A, et al. Comparison of angiographic and clinical outcome after cutting balloon and conventional balloon angioplasty in vessels smaller than 3 mm in diameter: a randomized trial. J Invasive Cardiol 1998; 10: 70-5.
9. Kurbaan AS, Kelly PA, Sigwart U. Cutting balloon angioplasty and stenting for aorto-ostial lesions. Heart 1997; 77: 350-2.
10. Yamaguchi T, Nakamura M, Nishida T, et al. Update on cutting balloon angioplasty. J Interven Cardiol 1998; 11 (suppl): S114-9.
11. Krysiak R, Okopien B, Herman Z. Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes. Drugs 2003; 63: 1821-54.
12. Barath P. Microsurgical dilatation concept: animal data. J Invasive Cardiol 1996; 8 (suppl): 2A-5A.
13. Inoue T, Sakai Y, Hoshi K, et al. Lower expression of neutrophil adhesion molecule indicates less vessel wall injury and might explain lower restenosis rate after cutting balloon angioplasty. Circulation 1998; 97: 2511-8.